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dialogue

		Balancing patient pain with ethical
treatment: a doctor’s dilemma
t h e m e dic a l prof e s sion has gone back and forth in its approach
to pain treatment. Alcohol and opioids, once seen as miraculous and
valid ways to assuage pain from injury or chronic disability, are now
viewed—and used—differently. Dean Robert J. Alpern, M.D., discusses
what has changed since he was trained as a physician—and what that
bodes for the future.
Has the landscape changed in terms of how the medical community discusses individuals
with substance use disorder challenges? Many years ago the treatment of pain was
dominated by the traditional philosophy of “do no harm.” We as physicians undertreated pain due to the fear of causing addiction and overdoses. Then there was a
period when medical professionals saw undertreatment of pain as a kind of harm,
and we went through a period of increasingly aggressive pain treatment, which led
to the development and expansion of pain as a specialty. Medical schools and health
systems began developing and expanding pain programs, because as it turns out, it’s
very difficult to treat pain effectively.
Most recently, we’ve seen that pain treatment that frequently relies on opioids has
secondary and even tertiary consequences, causing an epidemic of addiction and
overdoses. Now the medical profession is pulling back, trying to find the right balance.
Do you feel that part of the issue with substance use disorder surrounding pain medication
involves the idea that one should not have to feel any pain? No, I don’t think so. Medically,
you were always balancing the patient’s comfort with risk to the patient’s health. The
ideal would be to treat pain in ways that don’t involve opiates. Steve Waxman’s research
into blocking specific sodium channels that affect the sensation of pain is extremely
promising. But there’s a danger, too. If you block all pain sensation, a patient could burn
themselves and not know it. There’s a reason we feel pain.
What’s the School of Medicine’s role in the substance use disorder epidemic? Yale is very
strong in substance use disorder research. Our faculty in psychiatry, general internal
medicine, and emergency medicine are world-class experts on the subject. Substance
use disorder spans many variables so, while many of them work in opioid addiction,
others focus on tobacco, alcohol, food, and other things. In every case, Yale should be
among the first to take the most effective practices to the bedside. I hope that in the
near future, someone suffering pain will be able to receive treatment specific to their
ailment that isn’t addictive.

chronicle

»

			Patient navigators
address barriers to health care
priscilla wang, m.d. ’17, recalled a frightening moment
at her patient’s house. She watched in dismay as the man,
who had disabilities, clung for balance to flimsy towel bars
in his bathroom.
“It made me really upset. … He
could easily fall; he could break
his hip because of this unsafe
arrangement,” Wang said. Yet his
health insurance did not make
funds available to help prevent
a potentially catastrophic and
expensive injury.
“This experience was really
eye-opening, in that it made me
realize that it’s in the day-to-day
settings that health is determined,” she said.
The home visit took place as
part of a pilot patient navigators
program Wang co-founded in
2016. The Yale Patient Navigator
Program (PNP), pairs nine teams
of senior and junior medical students with patients from Yale’s
primary care clinics who face
serious social barriers to health.
Supported by lectures from faculty, social workers, and New
Haven outreach workers, and
through visits with patients, the
students learned to go beyond
brief clinical encounters in
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order to listen to and learn what
patients are up against, and provide meaningful support.
“Many of the problems we
address in the hospital are not
necessarily biological in their
root causes. There are many
ways in which medical students
can meaningfully address these
deeper issues,” said Wang, who
worked on the project before her
graduation last May.
Indeed, the quest for better
health asks a lot of patients—literacy, transportation, disposable
income. Being unable to read,
travel to the doctor’s office, or
pay for parking can derail even
the best medical advice. Many
people risk being fired if they
miss work for a doctor’s appointment. Others contend with
domestic abuse or the criminal

justice system. Cars break down,
buses don’t serve the neighborhood or don’t arrive, and missed
appointments ensue, which
can lead providers to discharge
patients from the clinic. People
may lack information about
healthful living or support for
quitting tobacco, or are confused
by their doctors’ instructions.
Some people simply mistrust the
health care system. Such problems don’t get much space in formal med school curricula.
So the student navigators
helped their patients make sense
of multiple bottles of medicine.
They connected people to food
assistance, discounted transportation, and low-income housing.
One man lacked a phone, so his
student team signed him up for
a free Obama Phone (cell phones
for low-income Americans).
Nisha Dalvie, then in her first
year of medical school, accompanied her patient, a man in
his 50s, to the courthouse for
help with housing; to his physical therapy; and to the housing
authority. Not only did he contend with diabetes and a condition causing muscular weakness,
but he also had low literacy. He
had trouble reading forms and
medication instructions, but he
didn’t want to attend a nearby
literacy program and reveal his
difficulty to people he’d known
since childhood. Dalvie and her
teammate, fourth-year medical student Sean Maroongroge,
helped him obtain tutoring in
another part of town where he
could study in anonymity.

T E R RY DAG R A D I P H OTO

“It was great to see how many
things were available for him by
basically just googling things and
emailing people, trying to figure
out what we could do,” Dalvie
said. “There’s so much out there,
and you really don’t learn it in
medical school.”
The PNP is an outgrowth of
Students for a Better Healthcare
System, which M.D./Ph.D. student Lorenzo Sewanan and several other students founded in
2012 to help educate New Haven
residents about the Affordable
Care Act. During teach-ins they
conducted in schools, churches,
and at the School of Medicine,
the students picked up on problems that go beyond health
insurance. “Even though more
and more people were having
‘access’ to health care or at least
health care insurance,” Sewanan
said, specifying the quotation
marks, “it didn’t necessarily mean they were getting to
receive the best care or getting
the benefits of that care.”
The difficult world some
patients inhabit was uncharted
territory for students like
Dalvie, who said she had a
privileged upbringing.
“There’s a lot of tension in this
city, I feel, between people who
are impoverished and the students, who are most often not,”
Dalvie said. “I hadn’t really seen
it like that in any other place
where I’d been, where those who
didn’t have as much were so in
the forefront of the city. … We
got to see how all of these issues
extend beyond the clinic.”

Co-founded by Wang,
Sewanan, Eamon Duffy,
Julianna Berk-Krauss, and
Matt Meizlish, and supported
by several physician advisors,
including Pinar Oray-Schrom,
M.D., HS ’02, assistant professor of medicine (general
medicine), the program completed its pilot year to rave
reviews from students who
participated. One student
called it “one of the most
formative experiences of my
Yale career.” Another wrote,
“There is nothing at Yale more
patient-centered than this.”
Patient navigation has its
roots in a program started by
Harold P. Freeman, M.D., in
Harlem in 1990 to assist primarily the poor and uninsured to
access cancer care; it grew to
become the Harold P. Freeman
Patient Navigation Institute,
which now trains navigators all

over the country. New Haven’s
Gateway Community College
also offers training.
Sewanan said the student
program was also inspired by
“hotspotting,” an approach pioneered by Jeffrey Brenner, M.D.,
in Camden, N.J., in which teams
of providers work directly with
high-risk patients who use the
most health care services. The
teams address social needs as
well as smoothing paths through
the health care system, with a
resulting drop in the need for
hospital services.
For Wang, learning more
about her patient’s life was such
a powerful experience that she
switched career plans while on
the residency interview trail.

First-year medical
student Nisha Dalvie
joined hoping to help
patients navigate the
health care system.
Volunteering with
the Patient Navigator
Program offered a way
to help the community
while also broadening
her understanding of
what types of challenges patients face.
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YSM offers a leg up
to students aspiring to
medical careers

online exclusives

Last November, Yale
School of Medicine
doctors, PhDs, lawyers, activists, and
recovering addicts
gathered to brainstorm solutions to the
epidemic of opioid use.
For more on story,
visit ymm.yale.edu/opioid
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Wang abandoned her plans to
train in categorical internal
medicine, instead landing a
last-minute spot in the primary
care residency at Harvard’s
Brigham and Women’s Hospital
in Boston—a change of heart for
someone who began medical
school interested in orthopaedic surgery.
“It’s a really humbling, a
really powerful experience to
step into a patient’s home and
see the challenges that they
live with on a day-to-day basis,”
she said.
This year, navigators are
expanding their reach to
include patients with diabetes and mental health issues.
They’re also adding students
from other fields, including
nursing students and social
work students from Southern
Connecticut State University.
With the Affordable Care
Act and social services under
threat in the current political
climate, patients and physicians face ever-stiffer headwinds. Still, Sewanan believes
that patients and medical
students possess the power to
make an impact. “If we can’t
achieve what we want at the
policy level,” Sewanan said, “I
think there’s still a lot that can
be done at the personal, individual level.”
— Jenny Blair, M.D. ’04

At the age of 42, Shermaine
Hutchins has more life experiences under his belt than many
of his classmates at the School of
Public Health. He was raised in
Daytona Beach, Florida, by a single
mother who provided for him
and his younger brother with her
wages as an aide in a retirement
home. He graduated from high
school in 1993, unsure of his path
in life, and climbed up the ladder
at McDonald’s from “fries to manager.” In 1998, he joined the Army,
trained as a medic, and served
on a humanitarian mission in
Nicaragua, where he cared for his
fellow troops and local villagers.
He mustered out in 2002, still
not knowing where life would
take him. A chance encounter in
a mall led to a job as a DJ at a radio
station that played rhythm and
blues and hip-hop. Again, he rose
up the ladder, continuing as an
on-air personality while taking on
behind-the-scenes roles in management and production. His career
took him to Ohio, where he saw the
writing on the wall for “terrestrial”
radio. Spotify, MP3 players, and
streaming services were changing how people listen to music
and challenging radio’s business
model. In search of a more secure
livelihood, Hutchins thought back
to his time as a medic and decided
to become a nurse. He began taking pre-med courses at Owens
Community College in Toledo.
Then, two things happened.
He decided he’d rather be in
health care management than in
clinical care. And he was accepted
into Yale’s Summer Medical

and Dental Education Program
(SMDEP). Yale, along with other
schools, had offered the program,
funded by the Robert Wood
Johnson Foundation, since 1997
to help college students from disadvantaged backgrounds learn
how to navigate the med school
application process and teach
them basic science knowledge
and communications skills.
In 2013, Hutchins was one
of 80 students from around the
country who came to Yale for the
six-week residential program.
He arrived with some trepidation. Ivy Leaguers, he was sure,
would be rich stuck-up snobs. “I
had all those preconceptions,” he
said. Instead, he found an accepting and welcoming environment
filled with “regular people who
just happened to be at Yale.”
At summer’s end, he returned
to Toledo with not just new skills
but also a new dream. He would
study at an Ivy League school.
“Everybody told me I was
crazy,” Hutchins said. “All I kept
hearing was, ‘You can’t do that.’ ”
He graduated from Bowling
Green State University in 2016
and that fall matriculated at the
School of Public Health, where
he’s on track to graduate with
a degree in health management in May 2018. This year, he’s
second in the program and he’s
the 2017 Cornell Scott Scholar,
an honor awarded each year by

the Community Foundation
for Greater New Haven to a Yale
public health student who demonstrates a commitment to community-based health care.
“I wouldn’t be here without
SMDEP,” Hutchins said. But the
program is no longer available at
Yale. Because Yale has no dental
school, it had to withdraw from
the national program in 2016.
When word came that Yale
could no longer participate in
SMDEP, Linda Jackson, director of diversity, inclusion, community engagement, and equity
at the medical school, and Darin
Latimore, M.D., deputy dean for
diversity and inclusion, decided
to launch a program that would
serve local community college
students. Jackson reached out to
officials at Gateway Community
College in New Haven and
Housatonic Community College
in Bridgeport. Last summer,
19 students attended the inaugural Yale Summer Enrichment
Medical Academy (YSEMA), a free
six-week program for students
interested in careers in medicine.
At an informational meeting
at Gateway in November, Jackson
told about 30 prospective students what to expect from this
year’s course, which will accept
up to 25 students.
“If you’re interested in being
a physician, physician assistant,
or nurse, this will help you on
that road,” said Jackson, herself a
graduate of Gateway. “We are getting you ready for the next step. It
is a very rigorous program. You
will learn a lot.”
Also at that session at Gateway
was Lauren Doninger, Ph.D., a
professor of psychology who
coordinates YSEMA at the community college.

“We really have identified the
population that the School of
Medicine is seeking to develop
and nurture—first-generation
students, DACA students, students who are underrepresented
in medicine,” she said. Too often,
she added, these are students
who, “when they say they want
to be a doctor, hear ‘You can be
an aide.’ ”
The program includes organic
chemistry, biology, writing and
communications, introduction to
research, and mentoring workshops.
“Clearly, it tells them what they
are in for down the road,” said
Antonios Pappantoniou, Ph.D., a
professor of biology at Housatonic
Community College. “Students
often don’t have an impression
of how much work it takes to get
into medical school. This gives
them some training in advance.”
An integral feature of the
course is meeting Yale students
like Hutchins, who shares the
experiences of many of the
students. Last year’s inaugural
YSEMA class included Felicia
Williams, a 45-year-old program manager for Goodwill. She
already has a bachelor’s degree
from Albertus Magnus College
in social science, but came
to Gateway to make a career
change. She’d like to become a
pharmacist. She found the program challenging but encouraging. “It makes me know that I

could be whatever I want to be,”
Williams said.
“It was overwhelming,” added
Ama Dondorful-Amos, who
took the course last summer
with Williams. Dondorful-Amos
arrived in the United States from
Ghana two years ago, and hopes to
become a pediatrician. “It opened
up new perspectives. I learned how
to run gels, how DNA replicates.”
For Beth Schmidt, the course
sent a message that at 51, she
too can aspire to medical school.
Medicine has been part of her
life since childhood. Both her
parents were medical corpsmen
in the U.S. Navy. She studied
art history in college but spent a
career as a marketer for medical
device companies. Although she
longed to study medicine, she
felt she couldn’t afford medical
school. After the YSEMA course
ended, she secured an internship at a lab at the medical school,
which became a paid position
in January. She couldn’t have
done it, she said, without a class
called Introduction to Research,
taught by Hutchins. “He was very
encouraging,” she said.
Such responses are gratifying
to Hutchins, who is determined
to use his story as an example to
others. Last summer, although he
had an internship with the CFO
of Partners HealthCare in Boston,
he returned to New Haven twice
a week to teach the research class.
But he also offered pep talks in
what is possible in life: such as
attending an Ivy League school.
“I remember that feeling that
no one is in your corner and no
one believes that you can do
it,” he said. “I wanted to be that
voice that told them that they
could do it.”
—John Curtis

Winter 2018

7

chronicle

»

The DNA repair–breast
cancer connection

online exclusives

2017 was a bad year
for natural disasters.
Hurricanes, floods,
and fire hit communities across the
U.S. Yale School of
Medicine alumni lived
and worked in many of
them, and took part in
leading relief efforts.
For more on story,
visit ymm.yale.edu/relief
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The gene known as BRCA1 (for
“breast cancer susceptibility
gene 1”) has a storied history. It
was the first gene identified as
contributing to familial breast
cancer risk, and its discovery in
1990 led scientists and doctors
to accept the theory that breast
cancer could be inherited. Now
experts know that having a mutation that inactivates the breast
cancer gene increases a woman’s
chances of getting breast cancer
about sixfold.
While scientists know much
about how dysfunctional BRCA1
protein leads to cancer, they
know little about what the protein actually does in cells. In a
paper published in Nature this
fall, Patrick Sung, D.Phil., professor of molecular biophysics
and biochemistry and of therapeutic radiology, reports findings
that shed light on the function of
the breast cancer protein in the
repair of broken DNA.
Sung has been studying the
homologous recombination
method of DNA repair for more
than 20 years. This DNA repair
mechanism takes place when
the cell is about to divide, after it
has duplicated its chromosomes—
bundles of double-stranded
DNA—but before each chromosome and its duplicate have
split off into separate cells. In
homologous recombination, a
large number of proteins function together to repair a DNA
break in one chromosome by
copying the broken section from

the duplicate chromosome to
patch up the break. First, for a
short distance on either side
of the break, one strand of the
DNA is shaved away to form a
single-stranded end. Next, each
single-stranded end inserts
itself between the two strands
of the duplicate chromosome in
order to copy the damaged DNA
section. Like an interloper at a
dance, the single-stranded end
gets between the other chromosome’s two strands, pushing
one of them aside and forming a
structure called a displacement
loop or D-loop.
In 1994, working in yeast,
Sung discovered that a protein
called RAD51 attaches itself to
the single-stranded end of the
broken DNA and leads the invasion of the duplicate chromosome. In 1997, another lab
learned that this invader protein
physically interacts with the
breast cancer protein. “We have
to study this,” Sung thought to
himself when he heard the news.
All of a sudden, his research
became related to breast cancer.
But yeast, the model system
Sung had been using, does not
have the breast cancer protein.
In order to study the interactions between the invader
protein and the breast cancer
protein, Sung had to shift his
research focus from yeast to
humans—or, rather, human cells
and proteins.
Sung and his team developed
a method to isolate a significant
quantity of the BRCA1 protein as
a complex with a partner protein

called BARD1. The researchers performed experiments to
test D-loop formation by RAD51
with and without the breast
cancer protein and its partner.
Those tests revealed that the
duo helps the invader protein to
form D-loops, and results from
experiments done in human cells
confirmed these findings.
This new information suggests, Sung said, that in breast
cancer patients with mutations
in the breast cancer gene, defective DNA repair likely leads to
cancer development. In this
regard, knowledge of how the
breast cancer protein works
could aid in drug development.
The findings could also
empower patients to make
important choices about their
treatment. In patients with a
family history of breast cancer, for example, doctors could
sequence the breast cancer
gene and the gene encoding its
partner to look for mutations
that might impede the pair’s
functioning. Further, it would
be possible, Sung said, to recreate a patient’s protein duo in
the laboratory and test its DNA
repair abilities to better assess
the patient’s cancer risk. “Being
able to apply this type of system
to look at patient mutations
will ultimately help patients to
make decisions, like whether to
get a mastectomy as a preventive measure,” Sung said. “It’s a
really big deal. It’s very important. Because it’s a huge decision
for anyone to make.”
—Ashley Taylor

a collection of recent
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YALE RESEARCHERS
HELP RESCUE
EXTINCT TORTOISES
For years before his death in 2012 in
the Galápagos Islands, people around
the world followed the sad saga of
“Lonesome George.” The hope was
that George, the last saddleback
tortoise of his species, would mate
before he died. While there wasn’t much anyone could do
for George, an international expedition from Yale found
23 tortoises with sufficient DNA to breed a different but
related saddleback species back into existence. Much will
depend on the ability of the nine males and 14 females
to procreate over successive generations. Announced
in September through the journal Scientific Reports, the
story may have to wait some time for a happy ending:
Saddleback tortoises don’t reach sexual maturity for a
quarter-century.

LESS THAN 1 PERCENT OF
NEURONS ORCHESTRATE
BRAIN DEVELOPMENT
It is a sign of enlightenment and
sophistication for a country to adopt
democratic methods of government. Not so with the brain, it seems!
According to research conducted by
a team including Jessica Cardin, Ph.D.,
associate professor in Yale’s Department of Neuroscience,
the brain takes a more top-down approach. Just 1 percent
of its neurons are responsible for its development. These
“VIP” neurons don’t have to worry about gerrymandering
or primaries—the other neurons obey their prompting
without question or complaint!

USSR: PUBLIC HEALTH
PIONEER
An exhibit at Yale’s Cushing/Whitney
Medical Library in October presented
viewers with an unusual spectacle—the
first health campaign to create an education program using posters designed
for use by the public. Developed by
graphic designers and artists working with doctors in the
Soviet Union in the 1920s, the campaign sought to diminish
the incidence of syphilis among an overwhelmingly rural and
uneducated population. While reliable numbers are difficult
to come by, one assumes that the public health campaign
made some headway in reducing transmission of the disease.

TRANSLATION OF WORLD’S
MOST MYSTERIOUS
MANUSCRIPT IS UNMADE
In September 2017, a television writer and
amateur decoder named Nicholas Gibbs
claimed to have deciphered the Voynich
manuscript. The Voynich is a unique
codex that dates from the 15th century
and resides in Yale’s Beinecke Library. It
has defied codebreakers for centuries
and generated a number of curious theories. Gibbs wrote in the Times Literary
Supplement that it was “a reference book
of selected remedies lifted from the standard treatises of the medieval period, an
instruction manual for the health and
well-being of the more well-to-do women
in society.” Case closed, right? Not so fast,
Lisa Fagin Davis, Ph.D. ’93, director of the
Medieval Academy of America, offered
a swift and authoritative rebuttal of the
Gibbs theory: “Frankly, I’m a little surprised
the TLS published it,” she said to Sarah
Zhang of The Atlantic. And so the enigma
remains unsolved.
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Shelter
from the storm
Improving treatment, exploring solutions
to the opioid crisis
AC C O R D I N G TO TH E C E NTE R S FO R D I S E A S E C O NTRO L AN D PR E V E N TI O N (CDC), approximately 88,000 Americans die each year from what they describe
as “excessive alcohol use.” Meanwhile, in 2016, the most recent year for which numbers
are available, drug overdoses accounted for 64,000 deaths—a figure that all indications suggest will be eclipsed by 2017’s numbers, when they become available. Given
that alcohol is easily available and socially acceptable, while the drugs that are killing
men, women, and young people are, hypothetically, difficult to procure, is all the more
disturbing that the gap between these figures is narrowing so quickly.
Overdose deaths have become the number one public health crisis in our country.
This issue of Yale Medicine Magazine explores how courageous faculty, students, and
alumni from Yale School of Medicine are working to gain control over the storm that is
raging through our country. From research into new types of pain treatment and patient care (“How treatment for addiction came out of the Dark Ages,” “Alternatives to
opioids”) to policy based on clinical experience (“Needed: better strategies for combating the opioid epidemic”), YSM clinicians and researchers actively seek to reduce and
destigmatize preventable death from this disease. It’s a daunting task.
The war over how to describe and treat substance use disorder has tremendously
high stakes. Yale School of Medicine has produced and continues to produce leaders
capable of posing ethical, empathetic, system-wide solutions to a deeply subversive
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affliction that, more than ever, holds American citizens in its grip.
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Needed: better strategies for
combating the opioid epidemic
For decades, doctors and community
advocates have worked together to
combat the epidemic of substance use
disorder. Lately, that battle has seemed
harder than ever.
by steve hamm | greg hall illustration
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In 2000, a doctor from tiny St. Paul, Virginia,
asked the School of Medicine for help with a terrible problem. Art Van Zee, M.D., a physician in
a community clinic, reported that opioid abuse
was sweeping Appalachian coal country like a
tsunami. People he had cared for since infancy
were overdosing on the prescription painkiller
OxyContin®. How could this disaster be stopped?
“Art was the canary in the coal mine,” recalls David
A. Fiellin, M.D., HS ’95, professor of medicine (general medicine), emergency medicine, and of public
health. Fiellin traveled to Virginia with Richard S.
Schottenfeld, M.D. ’76, HS ’82, FW ’84, then a professor
of psychiatry. They learned about the emerging rural
opioid abuse problem and gave treatment advice to
about 150 community members, health professionals,
and counselors gathered in a community center building near the Kentucky border.
Appalachia was ground zero of an epidemic that
has since ravaged the nation, with the drug of choice
shifting from OxyContin to the semi-synthetic opioids
heroin and fentanyl. “Unfortunately,” says Fiellin, “a
lot of what Art was concerned about has come true—all
over the country.”
More than 60,000 people died of drug overdose,
mostly from opioids, in the United States in 2016.
Opioids presently account for more deaths than gun
homicides and car crashes combined.
“Even though the country has been focused on this
issue for several years, the problem is getting exponentially worse, not better,” says U.S. Senator Christopher
Murphy, a Democrat from Connecticut. “The scope of
the epidemic is absolutely staggering. It’s not young or
old, black or white, rich or poor. It’s everybody.” Murphy
is pressing in Congress for increased funding for crisis
intervention, long-term treatment, and medication
therapy, and a crackdown on the drug companies and
physicians who push painkillers that aren’t necessary.

14

ymm.yale.edu

the state turns to yale
Addiction experts at Yale have been at the forefront of
treatment innovations since the 1970s, so it was no surprise when in 2016 Connecticut Governor Dannel P. Malloy
asked Fiellin and colleagues at Yale to take the lead in
designing a strategy to reduce opioid overdose deaths.
(The death toll in Connecticut reached 723 in 2015, 917 in
2016, and was projected to exceed 1,000 in 2017.) The result
was the Connecticut Opioid REsponse (CORE) initiative.
In October 2016 the initiative issued, in Yale’s Medical
Historical Library, a report based on input from Yale faculty, state agencies, hospitals, physicians, nonprofit groups,
and citizens.
“The solution to the opioid crisis has to be a multipronged approach,” says Fiellin. “We need to decrease
the availability of all types of opioids, and we need
to increase the availability of the most effective forms
of treatment.”
The CORE group recommended six strategies—all of
which are being acted on by state government leaders.
The first five were sharply focused—increased access to
treatment with methadone and buprenorphine; accelerated entry into treatment for individuals at high risk
of overdose; reduction of over-prescription of opioids;
increased access to naloxone to reverse the effects of
overdose; and increased sharing of data among state
agencies, medical clinics, and treatment centers. The
goal was a more rapid response to overdose outbreaks.
The sixth strategy was more sweeping: to increase
understanding of the nature of opioid use disorder and

the most effective ways to deal with it. This strategy is
critical, according to the Yale team, because much of
the conventional wisdom about how to deal with opioid use disorder is wrong.
“In essence,” says Gail D’Onofrio, M.S., M.D., professor
and chair of emergency medicine and a member of the
CORE team, “the goals are to reduce the stigma associated
with addiction and understand that it is a chronic, relapsing disease. It has nothing to do with a moral failing, and
all to do with a remodeling of the brain’s reward system
that is not easily corrected by short-term approaches such
as detoxification and enforced abstinence.”
an alternative to rehab
The conventional wisdom, endorsed by some government
leaders and health care professionals, is that the solution is
to send people to residential rehabilitation centers where,
after detoxification, patients are told to abstain completely.
Not so, says D’Onofrio. She describes this treatment of
addiction through abstinence as “potentially contributing
to the worst possible scenario. … When they are released,
the craving associated with certain cues is still there, but
now they have less tolerance. The risk of overdose and
death is very high.”
Research has shown that more than 90 percent of
those who go through detoxification and attempt abstinence will relapse within six months. Opioids rewire
the brain, causing intense cravings often impossible to
resist. Rather than detox and abstinence, which do little
to blunt the craving or undo the remodeling in the brain,
Yale experts advocate medication-based therapy. The
long-term use of such opioid agonists as methadone and
buprenorphine, they say, should not provide a “high”
but address the underlying cravings and allow people
to lead productive lives. Treatment with these medications has been shown to keep people in treatment while
decreasing cravings, withdrawal, criminal activity, and
death. Individuals can work, maintain interpersonal
relationships, and lead productive lives. Methadone
has, over five decades, proven effective in combating
heroin addiction. Buprenorphine was approved by the
U.S. Food and Drug Administration in 2003 after years
of advocacy by Yale faculty. Unlike methadone, it can
be prescribed by physicians outside of licensed opioid
treatment programs.

A study published by Fiellin and colleagues in JAMA:
The Journal of the American Medical Association
makes a strong case for long-term use of buprenorphine. In a clinical study of people with prescription
opioid dependence, those in the detoxification group
who tested positive for illicit opioid use 33 percent
more often than those in the buprenorphine maintenance group. Of the 57 patients in the detoxification group, only six stayed in treatment, compared
to 37 of 56 people in the group that received ongoing
buprenorphine.
“Treating people with buprenorphine has been one
of the most meaningful things I’ve done in 40 years as
a physician,” says Van Zee, the Virginia physician. “It
can transform people’s lives.”
One of Fiellin’s patients, Jay C., who did not want his
full name used, can attest to that. He was working as a
graphic designer 16 years ago when a dentist prescribed
an opioid painkiller after a tooth extraction. Jay loved the
euphoria, and soon he couldn’t live without the drug—
partly because he couldn’t face the agony of withdrawal.
He holed up in his house after he lost his job, and ultimately sold half of his possessions to buy drugs.
Buprenorphine “saved my life,” he says. Now, at
age 49, he’s the co-owner of an office cleaning company, has tapered his daily dose, and plans to get
off buprenorphine entirely. Still, he’s shaken by his
experience. “Opioids sink their claws in your soul,
and they never let go,” he says.
The Yale substance use disorder experts advocate
much more widespread use of buprenorphine and naloxone, the overdose antidote.
screening for care
For years, Yale clinicians have been using naloxone
in the emergency department for overdose victims.
Increasingly, police, first responders, and emergency
medical professionals use naloxone, but advocates want
to make the drug as prevalent as automatic defibrillators are in offices, stores, and restaurants. Currently,
patients who overdose in the Yale New Haven Hospital
ED are given a take-home dose of naloxone and
instructions for use. As early as 1999, Yale physicians
began screening ED patients for opioid and other substance use disorders as part of a pioneering program,
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Project ASSERT (Alcohol & Substance Abuse Services,
Education, and Referral to Treatment). Using a brief
negotiation interview (formerly known as an intervention) to motivate patients to change their substance
use, patients are directly linked by Health Promotion
Advocates employed by Yale New Haven Hospital to
community partners offering specialized care. The program has been very successful over the past 17 years;
almost two-thirds of all patients with a direct linkage to
community providers and programs enroll in treatment.
In 2015 D’Onofrio, Fiellin, and Yale colleagues published
the results of their study testing negotiation interviews
for patients with opioid use disorder in JAMA. Patients
offered a brief negotiation interview and ED-initiated
treatment with buprenorphine, followed by 10 weeks
of medical management in primary care led by Fiellin,
were compared with referral only and brief negotiation interview with a facilitated referral. ED-initiated
buprenorphine was found to be twice as effective as the
other negotiation interviews in engaging patients in formal addiction treatment at 30 days, at lower costs.
Buprenorphine and methadone have been found
effective for up to 80 percent of people with opioid use
disorder. Because buprenorphine is not as powerful as
methadone, it carries less risk of an overdose—doctors
can prescribe the medication after taking an eighthour course.
Prescribing buprenorphine in an office-based practice—as opposed to methadone in the clinic—allows
patients to preserve their anonymity if they choose.
It also helps them avoid running into former opioidusing associates—chance encounters that might promote relapse.
The U.S. Substance Abuse and Mental Health
Service Administration reports that 968 clinicians in
Connecticut are certified to prescribe buprenorphine
as of the end of September 2017, up from 594 at the
end of 2014. Yet, while the numbers are up significantly here and nationally, public health experts say
some communities remain underserved. “We have
to increase the number of prescribers,” says Robert
Heimer, M.Sc. ’80, Ph.D. ’88, professor of epidemiology
(microbial diseases) and of pharmacology at the School
of Public Health, and a member of the CORE team.
Needed, he says, are far-reaching education
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programs aimed at physicians. Caregivers in suburban
and rural areas, where opioids were not a major problem in the past, must be trained to spot and treat substance use disorders and reduce their misprescribing of
opioids, Heimer says.
Another critical need: increasing the capacity of
long-term treatment programs and expanding them
in underserved parts of Connecticut. Too often, people
who are referred for treatment must wait weeks or even
months to begin, or travel long distances to clinics.
As a result, there’s a high potential for continued opioid use with its attendant risks of overdose, arrest, and
such bloodborne infections as HIV, hepatitis C, endocarditis, and soft tissue infections. New Haven’s APT
Foundation, founded by Yale faculty in 1970 and one
of the country’s first methadone clinics, has scaled up
services to help everybody who walks in the door. Its
open-access model means a person with a drug problem can walk in without proof of insurance, be evaluated by a clinician, and obtain medication before the
end of the day. “We have reduced waiting time to zero,”
says Lynn M. Madden, APT’s chief executive officer.
The organization serves more than 8,000 patients a
year in Connecticut.
“We need APT Foundations all over the country,”
says Schottenfeld, now chair of psychiatry at Howard
University in Washington, D.C. APT’s open-access
model, he said, should be applied around the country
in areas where treatment slots become available only
when a patient dies or relapses. “That has been the traditional model, and it doesn’t work.”
a partnership with the state
Expanding services means more resources will be
needed. Despite Connecticut’s budget crisis (the state
is facing a deficit of more than $5 billion over the next
two years), the governor and legislators have committed to finding money to combat opioid addiction.
A host of state agencies, including the Department
of Mental Health & Addiction Services (DMHAS), has
partnered with Yale faculty on the CORE Initiative. The
DMHAS is now modifying or amplifying its efforts in
response to the group’s recommendations.
Miriam Delphin-Rittmon, Ph.D., FW ’02, the commissioner of DMHAS, applauds the CORE team for

using data to show what works—and what doesn’t.
“We don’t just implement these things and hope they
work. We implement them and measure their impacts,”
says Delphin-Rittmon, who is on leave from the faculty
of the School of Medicine.
One of the most innovative programs funded
by DMHAS in partnership with the Connecticut
Community for Addiction Recovery dispatches “recovery coaches” who help ED patients who seek longerterm treatment. When necessary, the coaches even
drive patients to treatment facilities. The program
recently expanded from four to seven hospitals around
the state. Still, Connecticut has 27 acute care hospitals,
so it is available to only a fraction of state residents.
A new program encouraging people to turn in
unused prescription opioid pills is off to a fast start.
More than 33,000 pounds of pills were collected last
year. Also, responding to new state regulations and
professional guidance, physicians are cutting back on
opioid prescriptions.
But doctors warn that responses to the opioid epidemic must be thought through—lest they adversely
affect patients. Jane L. Andrews, M.D., assistant professor of medicine, says limiting prescriptions puts
physicians in a bind. “What do I tell my 70-year-old
patient with arthritis who is getting 30 milligrams of
OxyContin a day, but still hurts? We need to find new
alternatives to opioids for long-term pain relief.”
Researchers in Yale’s Department of Psychiatry
are exploring nonpharmacological methods of dealing with pain—everything from cognitive behavior
therapy and biofeedback to tai chi and massage. They
see chronic pain as something to be managed rather
than “cured,” and they want to place greater responsibility for managing pain on the individual. They’re
investigating the effectiveness of smartphone apps that
help people care for themselves. “We’re trying to promote a cultural shift away from dependency on doctors
and drugs to solve problems,” says Robert D. Kerns,
Ph.D., a research psychologist at VA Connecticut
Healthcare System, West Haven Campus, and professor
of psychiatry, neurology, and psychology.
Other Yale researchers are exploring non-addictive
drug therapies that may eventually replace opioids for
some uses. Stephen Waxman, M.D., Ph.D., the Bridget

M. Flaherty Professor of Neurology, and director of the
Center for Neuroscience and Regeneration Research, is
working with pharmaceutical companies to develop
drugs that block sodium channels, which transmit
pain impulses through the nervous system (see story
on page 18).
changing attitudes
In the meantime, Yale’s addiction experts believe it will
be difficult to address today’s opioid epidemic without
changes in attitudes. To many people, addiction signals
a personal failing. Too often, those with drug problems
are shunned or treated like criminals, or they try to
hide their problems rather than seek help.
To meet Rachel Moore (not her real name), you
would never suspect that she’s recovering from heroin
addiction. The 29-year-old lab tech in New Haven is
bright and cheerful, and loves her job. She started
shooting heroin at age 16 “to fill a hole” in her life.
Now, after 11 years of methadone treatment and counseling, no relapses, and two college degrees, she’d like
to help break the stereotypes about drug addiction. Yet
none of her work colleagues know her secret. “Maybe if
I was more open and told people my story, I could help
change attitudes,” she says. “But I’m worried it would
change the way people viewed me. I think people forget there is a unique individual behind the addiction.”
Heimer of the School of Public Health says it’s time
for our society to replace shame with empathy and
understanding of addiction as a chronic relapsing disease. “We have to reduce the stigma associated with
addiction,” he says. “We have to stop calling people
names. They’re not ‘junkies’ or ‘addicts.’ They’re
people with a disease, and we have to get them into
treatment.” /yale medicine magazine
Steve Hamm is a contributor to Yale Medicine Magazine.
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Alternatives to opioids
How a Yale scientist is looking for
painkillers that target sodium channels,
not opioid receptors
by ashley p. taylor | greg hall illustration

Alternatives to opioids

Since ancient times, humans have used opium
and its derivatives to block pain. Yet in all that
time, no one has found a solution to two main
side effects of opioids—addiction and overdose.
Opioids block pain signals by stimulating opioid receptors in the spinal cord and brain. But they don’t work for
all types of chronic pain, says Stephen Waxman, M.D.,
Ph.D., the Bridget M. Flaherty Professor of Neurology
at Yale School of Medicine and director of the Center
for Neuroscience and Regeneration Research at the VA
Connecticut Healthcare System in West Haven. Many
patients with neuropathic pain—the result of nervous
system injury or dysfunction—get little or no relief.
Neuropathic pain, says Waxman, is “a very important unmet medical need.” It can occur after nerve
injury or shingles; in association with diabetes; or as a
response to chemotherapy.
“For all of these diseases, a common thread is that we
need better therapies,” Waxman says. He’s working to
develop such therapies, and he’s found a new target—not
opioid receptors but sodium channels, which neurons
need to fire.
For several years he’s been testing painkillers that
block sodium channels in patients with a rare genetic
disorder that sends their pain neurons into overdrive.
Waxman hopes to find treatments that will not only
ease common types of chronic pain but also reduce opioid use.
His search for non-opioid painkillers began at the
dentist’s office. Lidocaine, Novocaine, and all of the
“-caine” drugs in dentists’ needles are local anesthetics
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that stop neurons from transmitting pain signals by
blocking their sodium channels. But in pill form, those
drugs would have such unacceptable side effects as
double vision, seizures, sleepiness, and confusion, all a
consequence of blocking sodium channels in the brain.
A “holy grail of pain research,” Waxman says, is to find
a sodium channel that is essential to the function of
peripheral nerves that lie outside the brain and spinal
cord, but that does not play a major role in the brain.
Exploiting such a channel, he says, could block pain
without leading to side effects or addiction.
In the 1990s, scientists found such a channel, Nav1.7,
and Waxman’s lab began to study it. But drug companies wouldn’t pursue drugs targeting that channel
without proof that it had an important role in human
health. In 2003 Waxman began scouring the world for
people with inherited neuropathic pain, in hopes of
linking pain disorders to their particular mutations,
genes, and proteins.
He was still searching when a lab in China reported
in March 2004 that mutations in a gene, SCN9A, which
encodes Nav1.7, were the likely cause of the rare genetic
disorder inherited erythromelalgia (IEM). “Mild warmth
triggers intense burning pain, and many patients keep
their hands and feet on ice, to the point of getting tissue
damage, sometimes even gangrene,” Waxman says of
the disorder, also known as man-on-fire syndrome. At
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Atomic-level model of the
Nav1.7 sodium channel,
which is a master switch for
pain. This model is permitting scientists at Yale to
advance toward “precision,”
genomically guided medications for pain, which will not
have such side effects as
sleepiness or confusion, and
will not have the potential
for addiction.

first Waxman thought that the Chinese lab had beaten
him to the punch. But although the Chinese scientists
had linked the sodium channel to the disorder, they
had not shown how the channel works or how damage
to the sodium channel causes IEM. The Waxman lab
began investigating and later that year published their
results. The mutations in SCN9A, says Waxman, “make
the Nav1.7 channel overactive. And that makes painsignaling nerve cells shriek when they should be whispering.” Soon, Waxman’s lab received a grant from The
Erythromelalgia Association and what Waxman calls “a
much bigger gift”—access to a community of families
with erythromelalgia who have shared their DNA and
medical histories and participated in clinical trials.
In 2009 Waxman and colleagues reported that
patients with a particular SCN9A mutation responded
well to carbamazepine, which blocks all sodium
channels. Later, they used computer modeling of the
sodium channel to predict that people with IEM who
had a different SCN9A mutation might also respond to
the drug. A 2016 study at Yale confirmed their hypothesis. Waxman hopes to use genetics and computer
modeling in a “precision medicine” approach to predict drug responses in patients with other variations in
their genes.
In 2016, Waxman collaborated with Pfizer to test
another drug that, unlike carbamazepine, targets only

the sodium channel Nav1.7. Three of the five study participants responded to the drug in at least one of two
trials, and two participants responded to the drug on
both trials. In general, patients reported a three-point
reduction in pain on the 10-point scale. Waxman cautions that the number of patients studied was small.
Nevertheless, “That’s a fairly large improvement,”
Waxman says.
The scope of this research extends beyond IEM.
Waxman hopes that work on sodium-channel blockers will lead to the development of non-opioid medications to treat many kinds of chronic pain. Already
the British company Convergence Pharmaceuticals,
recently acquired by Biogen, has tested one Nav1.7
blocker as a treatment for trigeminal neuralgia,
which causes attacks of facial pain. Waxman is collaborating on that study, and early results are promising,
he says. Eventually, Waxman believes, these opioid
alternatives will be tested as treatments for back pain,
diabetic neuropathy, and more. “We need to do a lot
more work, and the numbers will tell the story, but
I am hopeful.” /yale medicine magazine
Ashley P. Taylor is a frequent contributor to Yale Medicine Magazine.
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The road back to
good health
Each year substance use disorder robs millions
of people of health, self-respect, and even life.
Patients who make their way to treatment follow
an arduous path.
by jenny blair, md ’04 | greg hall illustration
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The road back to good health

Before Kevin M.’s drinking problem began, before he
became what he calls a “frequent flyer” in the Yale New
Haven Hospital emergency department (ED), he was
a policeman in Hollywood, Florida. There, he became
involved in several shooting incidents. Though a civilian
review board determined he had been justified, he says,
he was asked to “leave the department quietly.”
Next, Kevin became a successful salesman of automatic
doors. Even as his business thrived and he found himself
in demand as an expert witness in automatic-door liability cases, he began to drink alone in hotels.
Then a $50 million lawsuit hit. It ruined his finances
as well as his marriage.
“That’s when my alcoholism really started to flourish,” says Kevin, now a 64-year-old retiree living in New
Haven. “I came back up north, broke, enraged, and just
kept drinking and drinking. My whole family didn’t
want me around.” Often homeless, hospitalized, or in jail,
Kevin spent over seven years in and out of the Yale ED.
And it was in the ED that Kevin connected with Project
ASSERT—and turned his life around.
The project’s deceptively simple mission: to screen
patients for substance use disorders, conduct a brief
negotiation interview, and refer patients to treatment
(a trio of actions abbreviated to SBIRT). It staffs the EDs
of both Yale New Haven Hospital (YNHH) and the Saint
Raphael campus with Health Promotion Advocates
(HPAs) trained to conduct the short interviews, which
help patients explore the pros and cons of substance use,
and begin to think about the possibility of change. For
those who feel ready, project staff can arrange for transfers to detox or rehab directly from the ED. Since the
program’s founding, it has arranged treatment for some
48,000 people. “We are their voice in the ED,” says HPA
Shevonne Mack.
In 2016, of all the patients the HPAs met with in
the ED, 22 percent went straight into treatment, while
another 43 percent received treatment referrals. Getting
people the substance abuse treatment they need is not
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only good patient care and good public health, resulting
in fewer ED visits due to injury, it may also be good economics. One 2005 study found that an ED-based program
saved $3.81 for every $1.00 it spent on an SBIRT program.
Gregory Johnson is a founding member of Project
ASSERT and one of several HPAs who worked with Kevin.
Johnson attributes the project’s successes to its home base
in the ED. Accosting people with substance use disorders
on the street may or may not lead anywhere—it’s all too
easy to toss an informational flyer, for instance. But an
ED visit can bring long waits and time for reflection—the
perfect opportunity for a caring outsider to offer help.
“If the patient recognizes that he has arrived at the
chest pain center because of cocaine and alcohol use and
I tell them ‘I can get you directly into treatment from the
ED, from point A to point B’, they’re more likely to say,
‘Let’s go for it,’ ” Johnson says.
The project began in 1999 as a one-year, grant-funded
initiative to help people with substance problems selfreflect via the brief negotiation interview. Within a few
months, its mission grew, according to Johnson. Not only
were HPAs finding at-risk drinking and drug use, they
were uncovering severe substance use disorders.
The normal procedure in such cases was to alert
social workers, who would refer patients for treatment.
But social workers often did not show up in the ED
when called, Johnson says. So he took matters into his
own hands. Having previously worked at New Haven’s
South Central Rehabilitation Center, he knew how
to get people into treatment, and he started doing so.
After the grant ran out, the hospital hired the team as
permanent employees.

“We became the substance treatment people,”
Johnson says.
In addition to short detox programs for the physically addicted, HPAs also arrange longer stays in rehab.
Project ASSERT also emphasizes harm reduction, offering
naloxone antidote kits, suboxone, and methadone clinic
appointments for some patients.
The idea of bringing public health initiatives like
this to the ED is partly that of Gail D’Onofrio, M.D.,
M.S., the chief of Emergency Services. D’Onofrio is a
renowned federally funded SBIRT expert who sees to it
that all primary-care resident physicians at Yale learn
the technique.
The HPAs credit much of their success to personal connections—among the community as well as to the patients
they serve. Being on a first-name basis with rehab and
detox workers all over the state can often open doors, for
instance, especially for patients whose insurance doesn’t

For Kevin, an HPA’s words at a crucial moment made
all the difference. One morning, he went to Yale New
Haven Hospital to collect belongings he’d left during a
discharge the previous day. He planned to hit the liquor
store next. But as he waited in the hospital atrium, one of
the HPAs spotted him and came to say hello. She asked
him if he’d been drinking that morning. He had.
“She sat and talked to me,” he recalls. “Something
went on in my head that said, ‘Are you ready to stop?’ ”
Kevin walked to the ED, where his blood pressure and
heart rate were found to be sky-high. That morning’s
drink turned out to be his last. After his discharge, he
became deeply involved with Alcoholics Anonymous. No
longer homeless, he spends up to four days a week at Yale
New Haven Hospital and the Saint Raphael campus, talking with others who struggle with alcoholism.
“I try to give them what was given to me, which is that
little light in your head that’s in that very dark place that

		Gregory Johnson

“If I say I can provide immediate help
		 for them, and I actually come through on
my word, that leaves an imprint on them.
cover treatment or who lack it altogether. And, recognizing patients’ difficult life circumstances, which can make
relapse hard to avoid, the team also works to connect them
to other area resources wherever possible.
That personal connection with patients can be especially important after relapse. Those who decide to try
again often ask for help from an HPA they’ve come to trust.
“I’ve had patients who call their mother and their
mother hangs up on them because they burned so many
bridges,” Johnson says. “If I say I can provide immediate
help for them, and I actually come through on my word,
that leaves an imprint on them.”

says, ‘You don’t have to live this way anymore,’ ” Kevin
says. “That’s what the folks over at the ER with the project over there do. … They never gave up on me.”
“You can’t be judgmental, and you’ve got to be
compassionate, and you’ve got to understand it’s a
disease,” says HPA Damaris Navarro. “They come
back, they’re going to come back, but that’s a part of
getting better.” /yale medicine magazine
Jenny Blair, M.D. ’04, a freelance writer based in Montpelier, Vermont,
has written frequently for Yale Medicine Magazine.
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History of substance abuse
For as long as they’ve had the ability,
humans have sought natural sources for
stimulation and relief from pain and injury.
compiled by adrian bonenberger
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12th century BCE Early references to “drink madness” from
ancient Egypt and Greece.

7,000–5,000 BCE Grapes
cultivated for wine in what is
now modern-day Georgia. And
they’re still making wine outside Tblisi today!
5,000 BCE Likely oral origins
of the Ayurveda, Hinduism’s
traditional medical system, in
which alcohol is prescribed
as a cure for certain ailments,
but not in excessive quantities—too much use of alcohol
is seen as damaging.

9th century BCE In Homer’s
Odyssey, Helen is described as
giving soldiers and veterans
of the Trojan War drugged
wine according to a recipe
discovered in Egypt—a magical potion called Nepenthes
pharmakon, or the antisorrow drug.

5th Century BCE Herodotus
makes references to drunkenness as a sickness of body
and soul.

3,400 BCE The opium poppy
is cultivated in lower Mesopotamia. Sumerians refer to it
as Hul Gil, the “joy plant.” The
Sumerians would soon pass
along the plant and its euphoric effects to the Assyrians.
The art of poppy-culling would
continue from the Assyrians
to the Babylonians, who in turn
would pass their knowledge
on to the Egyptians.

4th Century BCE Aristotle
(384–322), in comparing
licentiousness to drunkenness,
noted that the former was a
functional disorder while
the latter resulted from an
organic disorder. He viewed
licentiousness as permanent,
but drunkenness as curable.
When Alexander the Great
(Aristotle’s most famous
pupil) died in 323 BCE, his death
was ascribed partly to years of
immoderate drinking.

1st Century BCE The Yellow
Emperor’s Classic of Internal
Medicine, an organized and
systematic explanation of
acupuncture recognizable to
practitioners today, is published
in China. “These days, people
have changed their way of life,”
says the Yellow Emperor Huang
Di in the opening chapter. “They
drink wine as though it were
water, indulge excessively in
destructive activities, drain
their jing (the body’s essence
that is stored in the kidneys)
and deplete their qi [life force].”
The text treats alcoholism (and
other diseases or ailments) as a
behavioral problem, and recommends adjusting one’s behavior
to compensate.

98 AD Tacitus writes in
Germania, that German tribes
“ do not show the same selfcontrol in slaking their thirst.
If you indulge their intemperance by plying them with as
much drink as they desire, they
will be as easily conquered by
this besetting weakness as by
force of arms.”
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1st Century AD The Roman
philosopher Seneca (4 BCE–
65 AD) defines drunkenness
as a type of insanity. “The
word drunken is used in two
ways—in the one case of a
man who is loaded with wine
and has no control over himself; in the other, of a man who
is accustomed to get drunk,
and is a slave to the habit …
there is a great difference
between a man who is drunk
and a drunkard.”
4th Century AD St. John
Chrysostom compares inebriation to other known diseases.
He is, however, in favor of
using wine because of its
sacramental role in the Eucharist and its centrality in one of
Jesus’ best-known miracles.

5th century AD St. Benedict writes the Rule of Saint
Benedict, in which alcohol is
not prohibited. He notes that
monks who abstain from alcohol tend to be more virtuous.
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6th century AD Germanic
tribesmen prone to abusing
alcohol or drugs are encouraged to binge before battle.
Wearing wolf or bear skins,
given plenty of space by
their allies, these men were
deployed as berserkers (from
the Norse word for bear
shirt) and feared by their enemies. Three of these tribes,
the Angles, Saxons, and
Jutes claim Britain between
450 and 550 AD.

7th century AD Islam
founded. Islam’s attitude
toward alcohol differs
from that of Christianity.
Lacking the New Testament
descriptions of Christ’s use
and blessing of wine, Islam
is free to prohibit alcohol
completely, a prohibition
that stands to this day.
Although the prohibition
broadly concerns “intoxicants,” thus providing a religious rationale for banning
narcotics as well, early
Islam seems to have been
less strict in its attitude
toward the consumption
of nonalcoholic substances,
including coffee.

The Middle Ages (5th–
13th century AD) attitudes
toward drunkenness varied.
Some religious sects prohibited the use of substances
(the Ismaili Naziri or “Assassins”), while others permitted
or encouraged it (Benedictine
and Francescan monks); use
varied by culture and religious context. Overall, addiction was regarded as vice,
and treatment was either
nonexistent or focused on
spiritual redemption.

11th–12th century AD Medical students from Salerno,
Italy, build the first stills, enabling the distillation of spirits. This greatly increased
the potency of beverage
alcohol and spurred a worldwide surge in alcoholism.
12th–13th century Zhang
Sanfeng, whose exercises
allowed him to (allegedly)
live 152 years, establishes
the basis for Tai Chi, which
does not recognize a division
between the physical body
and the spirit. In addition to
exercises, Sanfeng’s teaching recommends abstaining
from alcohol, meat, beans,
and grains.

1560s–90s An early description of narcotic withdrawal,
cravings, and compulsions:
European explorers and scientists, in describing the opium
traffic among the Turks, Chinese, Moors, and Persians, note
of opium consumers: “If they
leave off somewhat taking it,
then they feel physically ill.”

14th century Italian scholar
Petrarch’s rediscovery of
humanist, pagan texts from
classical thinkers lays the
groundwork for the Renaissance and the Enlightenment.
Humanist scholarship also
plays a major role in the Protestant Reformation. While
some Protestant churches
(Lutheran, Anglican) continue
to permit the use of alcohol,
others adopt strict prohibitions against its use, including
some of the smaller groups
that help establish the English
colonies of North America.

1517 Sigismond de Dietrichstein organizes the Order of
Temperance in Germany. The
order calls for an end to the
custom of “pledging healths”
(toasts)—a practice thought
to promote intemperance.

1600 Dietrichstein’s Order of Temperance allowed
members no more than seven
alcoholic drinks per meal, and
only two meals per day. Well,
as the saying goes: “you have
to start somewhere.”

1620 Separatists, members
of a Puritan sect, settle New
England, and bring judgmental attitudes toward the use of
substances with them.
1747 The French philosopher
Condillac refers to inebriety
as a disease and calls for
state-sponsored treatment.

1606 Shakespeare’s Macbeth
offers a guarded evaluation of
the ills of drink—Lady Macbeth
drinks for courage to assassinate (“That which hath made
them drunk hath made me bold;
what hath quenched them
hath given me fire”) while King
Duncan and his guards have become vulnerable through drink.
The play may reflect evolving
Elizabethan attitudes toward
drunkenness. Alcohol was not
viewed as the problem, but
rather human dependence on it
for comfort. Drunkenness was
therefore a sign of moral weakness rather than disease.

1772 Physician and social reformer Benjamin Rush calls for
the abandonment of distilled
spirits and the substitution
of cider beer, wine, and nonalcoholic drinks in his sermons
to Gentlemen Upon Temperance and Exercise. Later, he
calls for the creation of special
hospitals for “inebriates,” following the notion that drink
(and not the drinker) was to
blame for alcoholism.
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1787–1813 Delirium tremens
(acute alcohol withdrawal syndrome) recognized and medically described by Lettsom,
Armstrong and Pearson, and
then named by Thomas Sutton.

1811 A temperance society in
Fairfield, Connecticut calls for
total abstinence, acknowledging that this is a harsh remedy,
“but the nature of the disease
absolutely requires it.”

1819 Christopher Wilhelm
Hufeland coins the term dipsomania to describe the uncontrollable craving for spirits that
triggers “drink storms.”
1789 First American temperance society organized in
Litchfield, Connecticut.

1826 American Temperance
Society formed—first national
temperance organization.

1799 China’s emperor, Kia King,
bans opium, making trade and
poppy cultivation illegal.

1825–1850 Temperance
movement abandons temperance (moderation) and
embraces total abstinence as
a goal and legal prohibition of
alcohol as a means of collectively achieving that goal.

Early 1800s In Boston, temperance advocates found a
brewery to provide beer to
those who pledged to forsake
“ardent spirits”—what we call
hard liquor.
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1830 The Connecticut State
Medical Society calls for creation of inebriate asylums.

1833 Dr. Samuel Woodward,
superintendent of the
Worcester Insane Hospital
and Women’s Lunatic
Asylum in Massachusetts,
writes a series of essays that
are published in 1836 and
again in 1838. “A large proportion of the intemperate in a
well-conducted institution
would be radically cured, and
would again go into society
with health reestablished,
diseased appetites removed,
with principles of temperance
well grounded and thoroughly
understood, so that they
would be afterwards safe
and sober men.”

1839 Lin Tse-Hsu, imperial
Chinese commissioner in
charge of suppressing opium
traffic, orders all foreign
traders to surrender their
opium. To protect its opium
trade, the British send expeditionary warships to the
coast of China, beginning the
first Opium War. By 1841, the
Chinese have lost the war,
and cede Hong Kong to the
United Kingdom.

1840–1890 More than 200
American water cure institutions include alcoholics and
addicts among their devoted
clientele and solicit their patronage through such media
as The Water Cure Journal.

1849 The Swedish physician
Magnus Huss introduces
the term “alcoholism” in his
text, Chronic Alcoholism; it
does not appear in the United
States until after the Civil War.

1853 The hypodermic syringe is developed as a refinement of the use of cannulae
to introduce drugs beneath
the skin. Morphine is one of
the first drugs for which the
syringe is commonly used
to treat such conditions as
facial neuralgia.

1856 The British and French
renew hostilities against China during the Second Opium
War. The import of opium is
legalized in China again.

1860 Alexander Peddie, a
Scottish physician practicing
in Edinburgh, calls for legal
commitment of dipsomaniacs to inebriate asylums. He
distinguished between common drunkards whose excessive drinking was a vice and
the “insane drinker” whose
vice had been transformed
into a disease no longer under
his volitional control. Peddie
believed this disease could be
inherited or acquired.

1861–65 Widespread use of
morphine during America’s
Civil War, along with the introduction of the hypodermic
syringe, lead to an epidemic
of opioid addiction among
veterans of the conflict; so
much so that opioid addiction
temporarily becomes known
as “soldier’s disease.”

1878 Britain passes the Opium Act with hopes of reducing opium consumption. The
selling of opium is restricted
to registered Chinese opium
smokers and Indian opium
eaters, while the Burmese
are strictly prohibited from
smoking opium.

1890 The U.S. Congress, in
its earliest law-enforcement
legislation on narcotics,
imposes a tax on opium and
morphine. Tabloids owned
by William Randolph Hearst
publish stories of white
women being seduced by
Chinese men and their opium
to invoke fear of the yellow
peril disguised as an antidrug campaign.
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1895 Heinrich Dreser, working for The Bayer Company of
Elberfeld, Germany, finds that
diluting morphine with acetyls
produces a drug without the
common side effects of morphine. Bayer begins production of diacetylmorphine and
coins the trade name “Heroin.”
Within a few years, the philanthropic Saint James Society in
the United States has mounted
a campaign to supply free
samples of heroin through the
mail to morphine addicts trying
to break their habit. By 1902,
physicians have begun to note
in various medical journals the
side effects of using heroin as
a morphine step-down cure.
Several physicians argued that
their patients suffered from
heroin withdrawal symptoms
equal to morphine addiction.

1905 U.S. Congress bans opium.
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1906 Several physicians
experiment with treatments
for heroin addiction. Alexander Lambert and Charles
B. Towns tout their popular
cure as the most “advanced,
effective, and compassionate cure” for heroin addiction. The Towns-Lambert
Cure consists of a seven-day
regimen, which includes
a five-day purge of heroin
from the addict’s system
with doses of belladonna
(nightshade) that often produces delirium. The patient
also receives other drugs
thought to be beneficial.

1914 The Harrison Narcotics
Act passes. It requires doctors,
pharmacists, and others who
prescribe narcotics to register
and pay a tax.

1923 The U.S. Treasury Department’s Narcotics Division (the first federal drug
agency) bans narcotics sales.
As a result, substance users
are forced to buy from illegal
street dealers.

1939 The first edition of the
basic text of Alcoholics Anonymous (AA), notes: “Then we
have a certain type of hard
drinker. He may have the habit
badly enough to gradually impair him physically and mentally. It may cause him to die a
few years before his time. If a
sufficiently strong reason—ill
health, falling in love, change
of environment, or the warning of a doctor—becomes
operative, this man can also
stop or moderate, although
he may find it difficult and
troublesome and may even
need medical attention.”
1944 Two “Yale Plan” clinics
open in Connecticut, one in
New Haven and one in Hartford.
The Clinics hope to develop a
plan for cost-effective assessment and treatment of people
suffering from alcoholism.

1960s Expansion of drug use
into white middle class youth
transforms attitudes and approaches toward treatment.
Shifting patterns of substance
use addiction during the
Vietnam War and Civil Rights
era lead to a massive cultural
divide in the U.S., leading to
a fundamental split between
conservative and progressive
lawmakers in their approach
to treating drug and alcohol
dependence.

1965-75 Involvement in Vietnam is blamed for the surge in
illegal heroin being smuggled
into the United States.

1970 The Controlled Substances Act of 1970 classifies
marijuana along with heroin
and LSD as a Schedule I drug—
high abuse potential, with no
accepted medical use.

1973 President Richard Nixon
creates the DEA (Drug Enforcement Administration)
under the Justice Department
to consolidate federal powers of drug enforcement in a
single agency.

1994 The Clinton Administration orders a shift in policy
away from the anti-drug campaigns of previous administrations. Instead focus includes
“institution building”—
included harsh sentences for
repeat offenders (also known
as the “Three Strikes” law).

2000 The Drug Addiction
Treatment Act facilitates the
treatment of chronic opioid
users by qualified doctors in
a clinical setting using approved Schedule III, IV, and
V narcotics.
2002 Buprenorphine is approved as a Schedule III drug,
and becomes the first approved as safe to use as treatment in a doctor’s office.

1985–93 New research extols
the positive effects of moderate drinking; the first “how-to”
books on controlled drinking
are published, contributing
to “Moderation Management,”
a moderation-based support
group alternative to AA.

With gratitude to William White, MD,
whose papers and timelines on the subject
supplied much of the background and
information for this timeline.
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How treatment for addiction
came out of the Dark Ages
Non-addictive pain medication has
changed how experts approach
therapy for substance use disorders.
by sonya collins | greg hall illustration
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“It’s not often that a psychiatrist gets to hear ‘Doctor,
you saved my life,’ ” said Ellen Edens, M.D., FW ’09,
assistant professor of psychiatry and associate fellowship director in addiction psychiatry. But she gets that
a lot from patients receiving outpatient treatment for
opioid use disorder. “They tell me, ‘I have my children
back, I’m working, I feel good.’ ”
Treatment for opioid use disorder hasn’t always brought
such clear rewards. Throughout the 1960s, abstinencebased detox was the only widely available treatment
despite high relapse rates. Then, in 1965, methadone
clinics emerged as a game-changer.
Rockefeller University clinicians Vincent Dole,
M.D., and Marie Nyswander, M.D., reported in JAMA:
Journal of the American Medical Association that
year that they had used once-daily oral methadone—
an opioid painkiller—to stabilize 22 young men who
were addicted to heroin. Methadone relieved both
withdrawal and cravings, and allowed patients to
resume their lives. On September 15, 1969, Robert
DuPont, M.D., who would become the first director of
the National Institute on Drug Abuse, started the first
methadone maintenance treatment program, which
served 25 parolees in Washington, D.C.
“That is when treatment for opioid use disorder
emerged from the Dark Ages,” said Patrick G. O’Connor,
M.D., M.P.H. ’88, FW ’88, the Dan Adams and Amanda
Adams Professor of General Medicine, and chief of general internal medicine.
As methadone clinics opened in cities around the country, studies showed that the treatment decreased drug
use and opioid overdoses, lowered hepatitis B and C rates,
improved pregnancy and birth outcomes, increased overall survival, and—crucially—lowered risk for HIV infection.
But the groundbreaking treatment wasn’t perfect.
Patients who landed a coveted spot in one of a handful of
licensed clinics had to show up every day for their dose
until they were deemed trustworthy enough to take a supply home. That process could take months. As heroin users
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tried to escape the soaring risk of HIV infection in the late
1980s, the model could barely support the demand.
“Here in New Haven, we had waiting lists of six
to 12 months for a slot in a methadone clinic,” said
O’Connor. “People were literally dying while they were
waiting for this highly effective treatment.”
O’Connor and colleagues at Yale knew there had to
be a better way. “What if we developed an approach to
treating opioid dependence that didn’t rely on one or
two methadone programs in New Haven, but rather was
available in primary care clinics and physicians’ offices
all over the city?” O’Connor asked.
chronic care for addiction
In a 1992 article in the Journal of General Internal
Medicine, O’Connor and colleagues showed that they
could manage withdrawal from heroin with clonidine,
a drug introduced in 1966 to treat high blood pressure and that was found to manage opioid withdrawal.
Once opioid-free, patients received naltrexone, an opioid blocker which renders them less able to feel “high”
or to overdose when they use heroin. Theoretically, the
medication would eliminate the stimulus to use opioids. But cravings persisted and patients often gave up
naltrexone and returned to using opioids.
Still, says O’Connor, “We showed that patients
would come to primary care for treatment and that
we had an effective protocol that could get them to a
drug-free state in an outpatient setting.” Integrating
addiction treatment into primary care has additional
benefits. This model would allow patients to receive
both addiction treatment and general medical care

“under one roof,” without the stigma of an addiction
treatment program.
Because patients often abandoned naltrexone,
O’Connor explored a new approach—using opioid maintenance therapy in primary care. Since methadone
could be used only in specialized programs, he performed the first randomized trial of primary care-based
buprenorphine—an experimental medication that had
been found as effective as methadone in specialized
treatment programs.
“Our study found that patients who received
buprenorphine in primary care did just as well as those
who received it in specialized addiction treatment settings,” said O’Connor.
Soon, the Drug Addiction Treatment Act of 2000
permitted physicians who met certain criteria to
treat opioid addiction in outpatient offices using FDAapproved Schedule III, IV, and V narcotics, although
none were available at that time. Two years later, the
FDA approved two drugs that fit the bill.
Subutex (buprenorphine hydrochloride), the partial
opioid agonist that O’Connor studied, could alleviate
withdrawal and cravings with less risk of overdose or
abuse than methadone. Suboxone (buprenorphine hydrochloride and naloxone hydrochloride) added naloxone to
decrease the risk of misuse. Both formulations could be
administered in a doctor’s office.
Medication-assisted therapy—Subutex or Suboxone
in addition to such psychosocial treatment as counseling—became the standard of care. “It was revolutionary,” said Edens. “One patient could be waiting to get
their blood pressure checked next to another who is
waiting to get Suboxone for opioid use disorder, and
nobody knows the difference.”
Researchers, including David A. Fiellin, M.D., HS ’94,
FW ’96, professor of medicine, challenged a longstanding belief when they began to show that treatment
with buprenorphine combined with primary care physician management was as effective as buprenorphine
combined with cognitive behavioral therapy.

of this neglect, physicians who want to treat patients
with buprenorphine must first attend an all-day
course. Federal law limits them to treating up to
275 patients at a time in a “qualified setting” that complies with information technology requirements and
makes counseling services available. For practical reasons clinicians rarely if ever treat the full 275 patients
allotted to them.
“It sends a message to physicians,” said Edens, “that
this is a dangerous or abusable system, but buprenorphine is so easy to use, and when it’s misused, it’s usually
for the exact reason we would use it: to treat withdrawal.”
But treatment for opioid use disorder won’t stop,
now that it’s treated as a chronic condition in an
outpatient setting in a manner similar to such other
chronic diseases as diabetes. “As with any other
chronic disease,” said O’Connor, “we’ll continue to
search for new and more effective medication and
psychosocial treatment approaches to improve health
and save lives.” /yale medicine magazine
Sonya Collins is a freelance writer in Atlanta, Georgia.

aligning evidence with policy
While treatment has advanced over the last 50 years,
policy and medical education lag. Medical school curricula spend little time on addiction. In part because
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A mother’s love
Spreading a Yale pediatrician’s intuitive, unorthodox,
effective treatment for opioid-dependent newborns.
by christopher hoffman | greg hall illustration

More than six months after his paper on his new
treatment for babies born to mothers addicted to opiates appeared in the journal Pediatrics, Matthew
Grossman, M.D., HS ’06, assistant professor of pediatrics, is seeing his methods slowly but steadily take
hold. [See “More mom, fewer drugs,” Yale Medicine
Magazine, Autumn 2016].
Boston Medical Center and Christus Regional
Medical Center in Santa Fe, New Mexico, have adopted
his approach, which reduces babies’ withdrawal time
by replacing drug therapy with increased contact
with their mothers. Hospitals in Camden, New Jersey,
and Canada, and state health collaboratives in New
Hampshire, Vermont, Maine, and Maryland are all
talking to him about introducing the protocol. Articles
highlighting his methods have appeared in The New
York Times and other publications. Inquiries from medical institutions have grown over the past 18 months
from infrequent to one or two a week in 2017, and
Grossman has traveled extensively to give talks and help
with implementation. “I don’t say no,” he says.
While he is gratified by the growing recognition
and use of his treatment, Grossman wishes it would be
adopted more quickly. Additional data collected at Yale
New Haven Hospital and other institutions have only
confirmed how well it works, he says.
Grossman’s key insight came in 2009 when he realized that babies who spent more time with their mothers
left the hospital after an average of 22 instead of 29 days.
That flew in the face of the all-but-universal and longstanding practice of taking babies born addicted to opiates from their mothers, putting them in intensive care,
and following a rigid protocol to assist their withdrawal
from morphine and other drugs. Grossman and his team

at Yale New Haven Hospital started experimenting to
see whether even more time with mom would further
speed withdrawal. The results were dramatic: the average
hospital stay plummeted by more than two-thirds to just
5.9 days, with most of the infants needing far less, (if any),
medication. “More mom, fewer drugs,” is how Grossman
sums it up.
Grossman is now working on a second paper that
expands on and reinforces his findings. He and his
team compared their actions under the new method
with the traditional method, the Finnegan Neonatal
Abstinence Scoring System. That method tracks 29
symptoms to determine whether a baby should receive
morphine or another drug. They found improvement,
for example, in 70 percent of babies who would have
received medication under the old system. Amazingly,
the Finnegan scoring method has never been extensively studied, he said.
Other works in progress include following the
babies to see how they do long term—Grossman has
met with the Yale Child Study Center about setting up
a monitoring program—and ensuring that the infants
receive any necessary services.
In retrospect, Grossman finds it amazing that hospitals have for so long used and continue to use the
Finnegan method. “The idea that we were separating
these babies from their source of love and their family
just seems terrible,” Grossman says, sitting in his narrow,
unadorned office at Yale New Haven Children’s Hospital.
“We have something that’s really good for babies and
really good for moms, really good for everyone. We think
it’s a much better way.” /yale medicine magazine
Christopher Hoffman is a freelance writer in North Haven, Connecticut.
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capsule
in New York, and the
donor of the comic books.
“Published imagery in
popular journals and magazines would be an important source of evidence.”
Hansen began collecting
comic books in the 1980s
after shifting his research from 14th-century
medicine. Advances
in medicine—stories of
medical progress and
breakthroughs like Walter
Reed’s vanquishing of
yellow fever in Cuba and
Edward Jenner’s discovery
of vaccination to prevent
smallpox—found their way
into the popular imagination. By the 1920s, medical
stories had become fodder for novels like Sinclair

		 Real Life Comics,
Advocates for Medicine
and Public Health
			 In their Golden Age in the 1940s, comic books
saluted medicine and public health … and paved the
			 way for improvements in human welfare.
		

By John Curtis

Lewis’s Arrowsmith. In the
1930s and 1940s Hollywood
joined in with movies
like Dr. Ehrlich’s Magic
Bullet, which dramatized
a cure for syphilis. And in
their Golden Age in the
1940s, comic books rhapsodized about the likes of
Louis Pasteur, Alexander
Fleming, Howard Florey,
and Clara Barton.
“The narrative of my
book, Picturing Medical

About two years ago the

Fever,” and “The Story

a question for which

Progress from Pasteur to

Medical Historical Library

of Medicine.”

there is little historical

Polio,” said Hansen, “is the

began adding a new cat-

documentation.

story of how we get the idea

egory to its collection of

source material for an

“How do we know

of medical progress and

scholarly tomes and ancient

undergraduate course

what ordinary people and

medical breakthroughs.”

treatises—comic books.

on medicine and the

patients thought about

Along with the works of

media, and are available

medicine, how they envi-

books took some license

Osler and Vesalius, library

to researchers exploring

sioned it, and what their

in focusing on the eureka

shelves now house issues of
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The comics are now

attitudes toward it were?”

Real Life Comics that

said Bert Hansen, Ph.D.,

tell stories like “Edward

professor emeritus of the

Jenner, Plague Fighter,”

history of medicine and

“The Conquest of Yellow

science at Baruch College

To be sure, the comic

moments rather than long,

During their Golden Age
in the 1940s, comic books
went beyond Superman
and Batman to tell the
stories of unsung heroes in
such fields as medicine and
public health. These heroes
solved medical puzzles
and surmounted obstacles
to improve medicine and
save lives. Their stories
popularized medicine and
public health and, scholars
say, inculcated the notion of
“medical citizenship.”

fruitless days in the lab.
And, added John Warner,
Ph.D., chair and Avalon
Professor of the History
of Medicine, the stories
often portrayed an “underdog,” a scientist with an
unconventional idea bucking the establishment, and
“this notion of a break-

TOP Real Life Comics issue

through moment.”

of April 1946 told the story
of Stephen Smith, a reformminded doctor in New York
City during the 19th century,
who campaigned for cleaner cities, public housing, and
public health. His advocacy
led to the founding of the
Metropolitan Health Board
in New York.

Even as medical and scientific accuracy took a back
seat to a good yarn, Warner
said, this popularization helped make medical
progress possible by lionizing heroes of medicine,

BOTTOM Ronald Ross, a
British physician in India,
and Giovanni Battista
Grossi, an Italian physician,
separately demonstrated
the role of mosquitoes
in the transmission of
malaria. Marvels of Science told their story in
November 1943.

research, and public health.
Their stories helped lay the
groundwork for clinical trials of the Salk polio vaccine
in the 1950s. “[The trials]
very much depended on
public health education and
the expectation of medical
progress and medical citizenship,” Warner said.

C O U R T E S Y M E D I C A L / H I S TO R I C A L L I B R A RY
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imagery that include com-
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library. There, Melissa

ics, magazines, and post-

of Medicine has a vigorous
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Grafe, Ph.D., the John
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program in the history of

launched a course in

R. Bumstead Librarian

posed are how media por-

medicine and faculty who

which Yale College stu-

for Medical History, and

trayals shape perceptions

are interested in media.

dents would explore how

Susan Wheeler, curator of

of the medical profession

the public has viewed

prints and drawings and

as well as perceptions of

would be preserved and

“I felt that the comics

medicine over the years—

historical medical posters,

health and illness within

actually used,” Hansen

Media and Medicine in

lead the students through

the medical community.

said. “That made Yale a

Modern America. Along

displays of popular health

with lectures and ses-

The course is one of

OPPOSITE PAGE, LEFT In
May 1946, Science Comics
told the story of Horace
Wells, a dentist who
realized that nitrous oxide,
also known as laughing
gas, could lead to painless
dentistry and surgery.
OPPOSITE PAGE, RIGHT

The summer 1946 issue
of Picture Stories from
Science described how
Walter Reed conducted
experiments with human
volunteers to defeat the
scourge of yellow fever.

special place.”

the reasons that Hansen

sions with teaching

donated his collection to

assistants in history, law,

the School of Medicine. He

medicine, and public

knew Warner from profes-

health, the course includes

sional conferences, but he
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Riding for
all the right reasons
six flats, three chains, two tires. Five thousand
one hundred miles, two legs, one patriotic and philanthropic Yale physician. Those numbers sketch the crosscountry odyssey of Andrés Martin, M.D., M.P.H. ’02, the
Riva Ariella Ritvo Professor in the Child Study Center and
professor of psychiatry, who climbed onto a bicycle on
August 17 in Seattle, Washington, and arrived over two
months later in Washington, D.C., no worse for wear.
“I loved every minute of it,”
Martin said.
The goal of that ambitious ride,
called Break the Cycle: to raise
awareness of and funding for
pediatric mental illness. Along
the road, Martin was joined by
a rotating cast of 49 fellow riders, including physicians and
family members of children
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with mental illness. They did
media interviews, held one-off
fundraising events—including a
spin class—and ultimately raised
over $200,000 for the American

Academy of Child and Adolescent
Psychiatry (AACAP). The organization represents what he calls
one of medicine’s most underserved specialties.
“The need is huge—even if we
quintupled the number of child
psychiatrists, it wouldn’t be
close to enough,” said Martin.
The money raised by the ride
will support research and help
to train new child psychiatrists,
as well as assisting children
with mental illness to access the
care they need.
A typical day on the road saw
Martin up by 5 a.m., climbing
onto his carbon-fiber Trek bike
by 7, and pedaling until midafternoon—about 100 miles a day.
Every evening, the experienced
triathlete climbed into an ice
bath to protect his legs from
inflammation, a routine so
effective that he never needed
Tylenol. Martin got lucky with
the weather, too: in 500 hours
on the road, he endured only
about four hours’ rain.
It was also Martin’s first
journey through the country as
a naturalized United States citizen. The son of Slovakian Jewish
Holocaust survivors who emigrated to Mexico, he earned his
medical degree in Mexico City.
He continued his medical training at the University of Miami
and at Massachusetts General
Hospital before joining Yale’s
faculty in 1996.
The trip was a “wonderful,
very granular way of getting to
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know the country,” Martin said.
“I’ve been grateful for all the
opportunities that America has
opened for me and for my family. I’m incredibly patriotic … .
Crossing the country coast to
coast, to feel the textures and
the smells and the sights, it’s
really, really deep and meaningful.” Some favorite memories:
Badlands National Monument
in South Dakota; a short ride

in Portland, Oregon, whose pace
was set by children; a man
with schizophrenia who
thanked the cyclists for their
work on his behalf.
Martin himself has faced
mental illness, and the ride

began as a personal journey.
Seven years ago, he took up
cycling as a way to cope with a
bout of serious depression, the
fourth such episode of his life.
Along with professional help and
a “dash of apt chemicals,” Martin
wrote in an AACAP editorial
called “Cyclotherapy,” cycling
helped him overcome depression.
After adding a cross-country trip
to his bucket list, he realized he

Andrés Martin, M.D.,
M.P.H. ’02, in Boston,
Massachusetts, nearing the end of his epic
months-long cross
country bicycle fundraiser. Over $200,000
was donated to Martin’s
ride on behalf of the
American Academy of
Child and Adolescent
Psychiatry (AACAP),
and he raised awareness
about the crucial issue
of child mental illness,
as well as how to service
those children who
need attention.
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online exclusives
Digitized medical
student theses have
been downloaded tens
of thousands of times
by researchers around
the world. Part of an
ongoing project to
bring as much human
knowledge as possible
online and advance
scientific inquiry, it is
run through the Medical Library with assistance from the office
of Alumni Affairs.
For more on digitized
theses, visit ymm.yale.
edu/theses
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could use the ride to give back to
his profession.
Given that stigma surrounding mental illness adds to the
difficulty many children face in
accessing psychiatric care, Martin
says it’s important to speak
openly about his own issues.
“If I as a psychiatrist don’t
talk about it, who will?” he
asked. “If all this is about
stigma, stigma, stigma, and
we dare not say the dirty name
of depression or other mental
illnesses, who will?”
At the end of 2017, Martin
stepped down after a 10-year
term as editor of the AACAP’s
journal. He is also AACAP’s
secretary-elect and a visiting
professor at Tel Aviv University.
In addition to mentorship,
research, and patient care,
Martin is a prolific writer with
many essays and reviews of
popular and scholarly books
in publication. He lives in New
Haven with his wife, Rebecca,
and their four children.
Break the Cycle was such
a success that Martin plans to
make it a franchise of sorts in
the child psychiatry community. For next year, he’s planning a two-day journey from
Vancouver, British Columbia, to
Seattle. A trip through Sweden
is also in the works for 2019.
In the process, Martin hopes
more of his colleagues will
begin to think of themselves
as clinician-philanthropists,
helping the organizations that
helped them at earlier stages of
their careers.

“The mentorship, training,
education, and early exposure of
folks going into this field—that’s
something that I’m really excited
about,” he said. “No matter what
branch of medicine you are in,
what you’re passionate about,
there’s a way of giving back.”
—Jenny Blair, M.D. ’04

»

Straddling science
and spirituality

Anna Yusim, M.D. ’06, a psychiatrist in New York City, has
spent much of the last decade
meditating on the often-invisible
intersection of science and spirituality—that ethereal sense of
connection to something greater
than oneself. Yusim herself took
to science seamlessly, but to spirituality slowly. Now, she’s demonstrating—in her practice and
her writing—how the two are far
from mutually exclusive.
“Science is the study of the
objective, measureable, quantifiable, testable, repeatable,”
Yusim said, “and spirituality,
by definition, is the opposite:
It’s transcendent, personal,
immanent, subjective, difficult
to measure quantifiably.” But
opposites need not be in conflict, Yusim maintains. Indeed,
their reconciliation is where
she found her own fulfillment—
and now invites readers to
find theirs in her debut book,
Fulfilled: How the Science
of Spirituality Can Help
You Live a Happier, More
Meaningful Life.

Until her residency at New
York University in 2006, “living
spiritually wasn’t a part of who
I was,” Yusim said. It was, however, a significant part of how
her mother saw the world during
Yusim’s childhood in Moscow.
Despite the difficulty of finding
religious and spiritual texts in
the Soviet Union, Yusim’s mother
avidly pursued books on Judaism,
Hare Krishna, and Buddhism,
among others. Yusim’s grandfather, Yefim, asked his deceased
wife to intercede when Yusim’s
family was awaiting visas to
immigrate to the United States in
1981. The visas came two weeks
later. At the age of 5, Yusim
arrived in Chicago with her
family. She took more after her
physics professor father, however,
who saw his Judaism as a cultural
rather than a spiritual identity.
The same scientific mindset carried Yusim into her time at the
Yale School of Medicine.
“Science was the currency
of knowledge and of exchange,”
Yusim said. “What led me to
pursue medicine was that I had
always been so interested in
the mind and how the mind
works.” But then came residency.
On paper, Yusim’s life looked
mapped out, tidy, fulfilled:
trudging valiantly through the
most rigorous step of her medical education, in a relationship
with a kind man, with a future
in a field she loved.
“Here I was, training to be a
psychiatrist and to help people
lift depression and anxiety from
their lives,” Yusim said. “So why
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was I feeling kind of depressed
and anxious myself? … I was
ready for my spiritual education
to begin.”
While maintaining her natural skepticism and a physician’s
analytic mindset, Yusim took
her first tentative steps into
where and how the “world of
spirit interacts with the world
of science.” She describes her
decade-long quest to unite the
two sides of human experience
as a key component of her life’s
purpose (alongside helping
her patients and nurturing her
marriage)—and the impetus for
writing Fulfilled. Having found
and defined that life purpose,
Yusim set out, through her psychiatric practice and the stories
of herself and her patients, to
help others—patients and readers—do the same.
“There’s no cookie-cutter
approach,” Yusim said.
Psychiatric and spiritual guidance is a relationship, she said.
“It’s really working with individuals to help them connect to the
soul in the most essential and
real way to them.” Integrating
medicine and spiritual practices like meditation has helped
Yusim identify goals for finding a
fulfilled life. “All of us face critical decision points where we can
choose to be authentic or not …
to align with our true selves or
with who we think we have to
be,” Yusim writes. “I know that
I am not alone in having lived
much of my life out of alignment with who I really am.” Her
realization of this misalignment

Anna Yusim, M.D. ’06,
spent her childhood
in secular Soviet
Moscow. Her father,
a physics professor,
viewed his Judaism
in cultural terms, and
Yusim entered Yale
School of Medicine
similarly predisposed
toward agnosticism. Since that time,
although studying
and practicing in a
scientific field, she has
come to appreciate
the importance of spirituality in her own life,
as well as its capacity
to help others.

came early in her psychiatry
residency. Yusim acknowledged
the veneer of perfection she’d
built around the emptiness she
felt inside, and set her sights on
abandoning that perfectionism
to address that root emptiness.
In Yusim’s experience, the
point of connection between
science and spirituality is everywhere. Literally. Spirituality
sees the world as more complicated and connected than
people perceive with their
senses—quantum physics says
the same. “According to quantum physics, at a level of reality
that is invisible to the human
eye, everything and everybody

is interconnected with one
another and to all living organisms,” Yusim writes.
“My hope is that people will
get a sense of how to integrate
more traditional medical training with the slightly less conventional spiritual approach,”
Yusim said. “They’re actually
not incompatible—you can tap
in and utilize many spiritual
principles and ideas in the service of healing.”
—Natasha Strydhorst
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question and answer

		 Putting children first
A F T E R T H E G R E AT R E C E S S I O N , researchers in pediatric health worried

that their field might suffer a permanent loss of funding. That concern faded
as U.S. research dollars increased in recent years, but Cliff Bogue, M.D.,
FW ’93, chair of Yale School of Medicine’s pediatric department, believes
even more money should be invested today in child health research. Before
and since taking the department’s helm in August 2017, Bogue has traveled to Washington, D.C., to advocate for more pediatric research funding
and resources from lawmakers and the National Institutes of Health (NIH).
For him, the calculus couldn’t be simpler. “Think of the results a treatment
could have on a 5-year-old who lives to 95, versus an 80-year-old who lives
15 more years,” Bogue says.

watch an interview
with Cliff Bogue at
ymm.yale.edu/bogue

to gather preliminary data on
Recent advances in genetics
collaborative projects and use
research suggest that many adult
the results to apply for larger NIH
diseases have origins that can be
grants. Bogue imagines projects
traced to childhood. If more data
that push the edges of medicine.
could be gathered from stud“You could have a geriatrician
ies that include children, those
working with a geneticist to idenrelationships could be examined
with greater certainty, Bogue said. tify biomarkers in Alzheimer’s
disease that can be found in
“One of the next broad themes in
childhood,” he says.
pediatric research will be what
Just like his childhood hero,
we call research across the life
Sherlock Holmes, Bogue thrives
span,” added Bogue, who has
on asking the right questions
served as chief medical officer
about patient care or a new scienof Yale New Haven Children’s
tific study. He recalls making his
Hospital since 2014.
career decision after shadowing a
Starting this year, the Yale
pediatrician as a high schooler in
Center for Clinical Investigation
his hometown of Tampa, Florida.
(YCCI) will roll out a pilot funding program on life span research. Bogue earned his medical degree
at the University of Virginia in
Researchers from across depart1985 and completed his pediatrics
ments at Yale will be encouraged
residency at Vanderbilt University.
He then devoted time to his passion for developmental biology

{ To nominate a subject for Q&A, contact
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research. After finishing a critical care fellowship at Yale, Bogue
joined its faculty in 1993.
Since then, pediatric research
has moved at warp speed, Bogue
says, especially as genetic
sequencing costs have settled to
affordable levels. He expects it to
continue apace. “Up to 30 percent
of patients we see in the pediatric intensive care unit are there
because something in their body
didn’t form correctly from birth.
Most of the time it’s a genetic
mutation,” Bogue said.
He sat down with Yale
Medicine Magazine to talk more
about research across the life
span, the single most important
activity for young children, and
the perils of too much screen time.

Q&A WITH

Cliff
Bogue

What does research
across the life span
mean? We are finding

burnout, about the cul-

that a surprising number

ture, and if clinicians

school and at a lot of
schools about physician

of diseases have their

feel valued. I’ve always

origins very early in the

they were exposed to

felt like this department

life span and they may

early in life. So much

has a personal touch, and

not manifest until years

evidence suggests the

that people are its greatest

later. If we understand

importance of reading to

resource. I think that’s

these and can identify

children at an early age.

important to continue.

What is the most memorable moment of your
career? There are quite a

what we are all about:

them, then we can intervene much earlier. For
our YCCI pilot program,
the idea is to get groups

It’s nice to remember
our privilege to care for
children and their fami-

of people together and

few memorable moments.

lies. To make lives better.

started on a project. We

All of them include

It’s something that most

want to investigate the

patient recovery. A year

people don’t get to do.

biological, environmental,

ago, I had visit from a for-

social, and psychological

mer patient, a young man

aspects of disease—many

now in his 20s, who had

of which have their ori-

had a severe head injury.

gins in childhood and

We didn’t think he would

even prenatally.

CONDUCTED BY

Kathleen Raven

do much except be in bed
the rest of his life. But he

What is the single most
important thing a parent can do for his or her
child? I think we should

pulled through and went

worry about the increas-

just won a gold medal at

ing amount of time chil-

the Paralympics in Brazil.

through rehabilitation
therapy. He came back
to see me because he had

dren spend watching a
or video games or iPads,

What will be your priority as chair? Much of

and less time spent inter-

my focus will be what

screen, whether it be TV

acting with others. This

all chairs must focus

constant screen time can

on, which is being an

actually change the neu-

international leader in

ral networks in the brain.

research, education,

One way to counteract

clinical care, innova-

this is through reading

tion, and collaboration.

and actively playing. If

Another thing that is

there was a single greatest

important to me is that

predictor of how someone

our department main-

will do in life, it is based

tains an environment in

on how much vocabulary

which people feel valued
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and excited to be here.
There’s been a lot of discussion in our medical
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book review

			 The Schmuck in My Office:
How to Deal Effectively with
			 Difficult People at Work
By Cathy Shufro
Move over, Birds of North

underlies these behaviors,

safety of our patients.” The

America and World’s Top

explaining that the arrogance

Joint Commission issued a

tor when Joy edited the Yale

Restaurants. Make room

and bluster are compensatory:

Sentinel Event Alert in 2008

Journal of Humanities in

for a new field guide—to

“In his most private moments,

warning that workplace strife

Medicine. Joy also worked
with the late gastroenter-

obnoxious co-workers.

the Narcissus fears that he

can lead to errors. Disruptive

The Schmuck in My Office:

isn’t all that great.”

and intimidating behaviors

ologist and writer Howard

may also hasten employee

M. Spiro, M.D., and partici-

turnover and increase costs.

pated in a writing group led

How to Deal Effectively with

So how to endure the

Difficult People at Work

narcissist who wreaks

helps readers reduce fric-

havoc in the workplace? It

tion with unruly colleagues

helps if co-workers respond

cipal author, in 2013 when

M.D. ’59, now professor emer-

by understanding the

promptly to requests or invi-

Foster was her attending

itus of psychiatry.

psychological and biological

tations, because narcissists

on the acute psychosis unit

Joy and Foster don’t
intend the book to be a

Joy met Foster, the prin-

by psychiatrist John Strauss,

causes of their behavior. The

are quick to feel snubbed.

at Pennsylvania Hospital in

authors, both psychiatrists,

Managers can prevent them

Philadelphia. Foster chairs the

diagnostic tool, but rather a

identify disruptive personal-

from hogging credit by

hospital psychiatry depart-

rough guide to what makes

ity types and offer strategies

rewarding teamwork more

ment and serves as a clinical

co-workers irritating. “No

for working with them.

than solo efforts. And col-

professor at the University

person is going to exactly fit

Jody J. Foster, M.D., M.B.A.

leagues can help narcissists

of Pennsylvania’s Perelman

into one category and not the

and Michelle Joy, M.D. ’12, use

digest criticism by deliver-

School of Medicine. Joy now

other,” Joy said. “You can get

stories to illustrate the traits

ing it inside a “compliment

works at the Philadelphia VA

a sense of what ballpark to

of 10 personality types that

sandwich” that begins and

Medical Center.

include the Narcissus, the

ends with praise.

Bean Counter, the Venus Fly

Readers will benefit from

During the five years

go to: ‘OK, the Robotic fits,
but maybe the Bean Counter

required to pitch, write, and

kind of fits, too.’ Because

such strategizing, Joy noted

edit the book, Joy said the

often there’s an overlap.”

Robotic. The Narcissus, for

in a recent interview. “If

partnership worked well

example, is someone (usually

you’re having a hard time

because Foster has experience

Trap, the Distracted, and the

Foster and Joy counsel
empathy (and sometimes

male) who expects others to

at work because of a dif-

at the intersection of psy-

therapy) for the irritating co-

cater to him, seeks attention,

ficult person, it can make a

chiatry and institutional cul-

worker. “They’re not setting

fishes for compliments, sulks,

huge proportion of your life

ture, and a master’s from the

out to be a difficult person,”

frames insults as jokes, and

uncomfortable. But it’s not

Wharton School, while Joy has

said Joy. “They’re struggling

spreads rumors. Colleagues

just about how happy we are

a long-time interest in writing.

with their own anxieties,

may find themselves treating

at work. It’s also about the

a narcissist like a glass orna-

Joy found time to write
while at Yale School of Medi-

ment for fear of offending

cine. Physician-author Randi

him. The book explores what

Hutter Epstein, M.D. ’90,
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M.P.H., M.S., served as a men-

their own insecurities.”
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end note

Auction raises $13,000
for hunger and homelessness
OV E R 2 5 Y E A R S , through an annual auction, students in the health professions have supported New

Haven nonprofits that address issues of hunger and homelessness. “They are taking a more holistic
approach to the issue of not having access to food,” said second-year medical student David Dupee,
one of the auction organizers, as he addressed the crowd at the auction in Café Med on Dec. 7. “They
are providing access to health care providers, social workers, and other resources that really address
the context in which social inequality occurs. All of these programs depend on us.”
This year, the 25th Annual Hunger and Homelessness Auction raised $13,000 that will be distributed to Y2Y New Haven, Jewish Family Services, and Integrated Refugee and Immigrant Services.
—John Curtis
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